NEWPORT BEACH, CA--(NewMediaWire - Feb 21, 2017) - ADVANTIS
CORPORATION (OTC
PINK: ADVT) begins distribution of topical cannabis
roll-on and Tinctures to treat pain conditions.
Advantis Corp has been developing innovative products for the
treatment of pain conditions since hiring their CEO, Christopher
Swartz. Mr. Swartz has been involved in alternative and
conventional treatments for pain for over 12 years and has worked
in consulting rolls with some of the largest companies in the
country. He stated, "We have seen the problem with chronic
pain conditions increase exponentially and with that, opiate misuse
and addiction as well. I have personally seen all this happen
and have observed (too many times) people whom have lost
hope." Mr. Swartz further explained, "I have been passionate
about creating solutions to effectively treat the masses without
the negative side effects associated with opioids. Elixcure is
the answer, and we are excited beyond belief to share this remedy
with everyone in need."
Elixicure is a line of CBD dominant products used to treat pain
without the psychoactive effects associated with
THC. Elixicure's Pain Relief Roll-On is specially formulated,
using the extract of the cannabis plant, which contains the
principal cannabinoid CBD (cannabidiol). The Pain Cream Includes
over 90% Certified Organic ingredients and is specially formulated
with Counter-Irritants to block pain receptors and Salicylic Acids
to provide a deep penetrating Aspirin-like relief. "Elixicure
utilizes the purest, pharmaceutically derived essential oils and
active ingredients to create products that are superior in quality
than those available in the marketplace today, and we are very
excited to add them to our rapidly growing portfolio of products,"
said Mr. Swartz in a recent press conference.
CBD products can be shipped to all 50 states, and Advantis Corp
has also been on an all-out media blitz to provide exposure to
deliver attention to their progress and product lines. With
this in mind, they hired UFC Legend Kimo Leopoldo as a brand
ambassador. MMA has been the fastest growing sport over the
last decade, and many high-profile fighters have been lobbying to
make CBD remedies legal. Kimo stated, "My passion for fighting
has been a painful one. The day-to-day grind in the gym as
well as the battles in The Octagon left me with aches and pains.
The doctors prescribe medicines that may help with this pain, but
the side effects from those medicines outweigh the
benefits. The Elixicure line of products have relieved my pain
with zero side effects."
The Elixicure news comes at a great time for Advantis Corp, as
they continue to expand their plains to add products (and entire
product categories) to their growing product portfolio. Swartz
indicated back in December that the company has active plans to
establish its foothold in other states, and during that press
conference, he also stated, "revenue is about to explode, and I'm
excited to share what all the company efforts are leading to, as
well as how Advantis will evolve in 2017." Swartz further
exclaimed: "I see this momentum continuing for the foreseeable
future, and we are poised to achieve our highest revenue ever in
2017."
Links to Advantis websites can be found at advantiscorp.com, elixicure.com, rosin6.com, and amstercan.com
Forward Looking Statements: This news release contains
forward-looking statements made by ADVANTIS CORPORATION. All such
statements included in this press release, other than statements of
historical fact, are forward-looking statements. Although
management believes that the expectations reflected in such
forward-looking statements are reasonable, it can give no assurance
that such expectations will prove to have been correct. Actual
results may differ materially from those indicated by these
statements. The following risk factors, among others, could cause
actual results to differ materially from those described in any
forward-looking statements. These risks and uncertainties include,
but are not limited to, economic conditions, changes in the law or
regulations, demand for products of the Company, the effects of
competition and other factors that could cause actual results to
differ materially from those projected or represented in the
forward looking statements. Forward-looking statements are
typically identified by the words: believe, expect, anticipate,
intend, estimate, and similar expressions or which by their nature
refer to future events. The Company is not entitled to rely on the
safe harbor provisions of Section 27A of the Securities Act of 1933
and Section 21E of the Securities Exchange Act of 1934 because it
is not registered under either act.